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The multivariate analysis adjusted for the following confounders
determined at the baseline interview and examination: age; gen-
der; race; Body Mass Index; quadriceps strength; family history of
knee replacement, frequent knee bending, physical activity over
the past month; varus knee alignment assessed by goniometer;
and presence of Hebeden’s nodes.
Results: Of the 4982 knees evaluated,1963 (39%) had FKSx.
Of knees with FKSx, 49.9% (980/1963) had TF-ROA, compared
to 39.8% (1202/3019) in those without FKSx. The multivariate
aOR’s for the association of knee injury and knee surgery vari-
ables with TF-ROA are summarized in Table 1.
Conclusions: Previous knee injury, knee surgery and knee
injury resulting in surgery and most types of knee surgery are
all strongly associated with TF-ROA in knees both with and
without FKSx even after adjusting for potential confounders in this
cross-sectional study. These ﬁndings and the particulary strong
association of ligamentous surgery with TF-ROA in symptomatic
knees warrant further investigation in the prospective analysis of
OAI and other longitudinal cohorts.
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Purpose: Arthritis is not only a signiﬁcant contributor to ab-
senteeism, but also presenteeism. Improved measurement of
productivity losses experienced by workers is needed to better
assess the impact of arthritis, in terms of the extent of at-work
disability and economic burden. The suitability of existing pre-
senteeism measures for individuals with osteoarthritis (OA) and
the comparative psychometric performance of these measures in
this population are currently unknown. The present aim is to con-
currently compare the measurement properties of ﬁve measures
of “at-work disability” in a sample of workers with OA.
Methods: Longitudinal data (baseline and 12 month follow-up) of
130 workers with OA were recruited from community and clinical
samples. Measures included the Workplace Activity Limitations
Scale (WALS), Standard Presenteeism Scale (SPS), Work In-
stability Scale for Rheumatoid Arthritis (WIS-RA), Endicott Work
Productivity Scale (EWPS), and Work Limitations Questionnaire
(WLQ). Score distributions (ﬂoor/ceiling effects), internal consis-
tency (Cronbach’s alpha, KR-20), construct validity (Spearman
correlation coefﬁcients, ANOVA), responsiveness [standardized
response means (SRM)], and patient preference were evaluated.
Results: Study sample [mean age = 54.0 years (sd = 6.7),
80.5% female] consisted of 40.5% who had been diagnosed with
OA for more than 1 year, and 49.2% who had been diagnosed
for more than 5 years. Presenteeism scores were generally
in the low (disability) end in all scales. Only SPS-6 showed
signiﬁcant ﬂoor effects (17%). Four of ﬁve scales demonstrated
high internal consistency (0.89 - 0.94) except for the SPS-
6 (0.75). At work disability scores showed moderate-to-high
correlations (0.59 - 0.78) with work constructs (self-reported work
productivity, intrusion of arthritis on work ability, and generic work
role) as well as logical and statistically signiﬁcant (p= 0.05 corr.)
gradients across workers hindered by arthritis at various levels
(very much, to a degree, not at all). Comparatively, the WIS-
RA showed the strongest correlations to work constructs (0.74
- 0.77). Correlations between presenteeism scales were only
moderate (0.46 - 0.71) suggesting different response patterns.
The WALS (SRM = 0.88) and WIS-RA (SRM = 0.82) were most
responsive to self-reported improvements in work ability after 12
months (SRM = 0.30 - 0.48 for other measures). The WALS
(34.7%) was the most preferred measure by the participants,
while the SPS-6 was least preferred (3.3%).
Conclusions: Despite initially developed for persons with
rheumatoid arthritis, the WIS-RA stood out as a measure exhibit-
ing the strongest psychometric properties, and therefore should
be favored for evaluating mismatches between work demands
and abilities of workers. The WALS should also be strongly
considered as it similarly demonstrated strong measurement
properties, and was the most preferred by respondents. Psy-
chometric concerns and low patient preference suggest that the
SPS may be least suitable among these ﬁve instruments.
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Purpose: To describe the ultrasonographic (US) ﬁndings in a
Spanish cohort of patients with knee osteoarthritis (KOA). These
US ﬁndings were compared with clinical and functional charac-
teristics.
Methods: 433 patients: 69% women, 31% men, mean ± SD,
58.4 ± 13,4 years) with primary KOA according to the ACR
criteria were included. The body mass index was greater than
27 in 70% of the patients. The patients were referred for the
study by their general practitioner who previously had performed
a clinical history and a physical examination. All patients ﬁlled-
out the Womac OA questionnaire, the analogical visual scale
and the SF12 questionnaire. All underwent a US examination
(Philips U22, Seattle, USA) of both knees by 20 sonographers,
following the EULAR guidelines, that included the presence of
synovitis (deﬁned by OMERACT) in the suprapatellar recess
and parapatellar medial and lateral recesses; medial and lateral
osteophytes; quadricipital and patellar enthesophytes; Baker’s
cyst, and meniscal extrusion (deﬁned as a distance greater than
2 mm between the edge of the meniscus and the outer part of
the tibia with the knee fully extended). Most of the US examiners
had more than 10 years of experience in musculoskeletal US.
Eleven sonographers with less than 10 years experience were
trained in US for the study. The interobserver study performed
after the training period revealed an average overall agreement
of 90% for all of the parameters included in the study. Informed
consent was obtained from all patients prior to the clinical and
US examination.
Results: The mean ± SD number of pathological ﬁndings
in patient was 7.93± 4.23.These ﬁndings were: quadricipital
enthesophyte (64.29%); medial osteophytes (59.68%); lateral
osteophytes (54.38%); meniscal extrusion (51.38%); and syn-
ovitis/effusion in anterior recess (50.23%). Functional score
of the SF 12 questionnaire was worse in patients with lat-
eral osteophytes (40.83 ± 6.90), synovitis in the suprapatel-
lar recess (40.24 ± 7.10), synovitis in the medial parapatel-
lar recess (40.29, ±8.4) and in the lateral parapatellar re-
cess lateral (40.49 ±8.48) vs. those that did not have: lat-
eral osteophytes(42.42±8.48, p=0.041), synovitis in the supra-
patellar recess (42.88±8.05, p=0.0001), synovitis in the me-
dial parapatellar recess(42.04±7.78, p=0.040) and synovitis
in the lateral parapatellar recess (42.26±7.71, p=0.023). Pain
score in WOMAC scale was worse in patients with medial
osteophyte (8.97 ±4.27, p<0.0001), lateral osteophyte (9.09
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±4.19, p<0.0001), synovitis in the suprapatellar recess (8.83
±4.22, p=0.009), and medial parapatellar recesses (9.15 ±4.20,
p=0.042) v.s those patients that did not have.
Stiffness score in WOMAC questionnaire was affected by the
presence of lateral osteophyte (4.02 ±1.95, p=0.001) and the
functional capability was modiﬁed because of the presence of
lateral osteophyte (32.54 ±13.74, p<0.0001), medial osteophyte
(32.17 ±14.4, p<0.0001) and synovitis in the suprapatellar re-
cess (31.72 ±14.26, p=0.001).
Conclusions: -In our population, the most frequent US ﬁnd-
ing was quadricipital enthesophytes. Suprapatellar synovitis was
found in more than half of the patients with symptomatic KOA.
There was a relationship between the number of pathological US
ﬁndings and pain (namely when walking and going up staired),
stiffness and functional ability scores.
Acknowledgements for their collaboration: Ponce A., Díaz-Cor-
dovés G., Fernando JL., Pinto JA., González L., Alcalde M.,
Cobo, T., Vicente E., Rodríguez A., Collado P., Jiménez M.
Grant from Lab Zambon (ECOGNOSIS)
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Purpose: Studies suggest that some minority groups, especially
African-Americans with osteoarthritis, may be at risk for higher
rates of pain and disability compared to Caucasian Americans.
In addition, African-Americans are less likely to undergo arthro-
plasty compared to Caucasian Americans. Some studies show
that female gender is associated with arthritis impairment. How-
ever, more research needs to be done to evaluate the role of age,
gender, socioeconomic status, and other predictors of arthritis
impairment among minorities and Caucasian Americans.
Methods: The ﬁndings from the population-based 1998 National
Health Interview Survey (N=30,534 adults) were used. Descrip-
tive and correlational procedures evaluated possible Black/White
differences in arthritis impairment related to walking ¼ of a mile
without special equipment.
Results: The null hypothesis was mostly rejected. African-
American women with household incomes less than $20,000
who report that arthritis impairs their daily activities were more
likely than Caucasian-American and African-American men with
arthritis impairment in different income groups to be unable to
walk ¼ of a mile without special equipment. For example, African-
American women with household incomes less than $20,000
who report that arthritis impairs their daily activities were more
likely than Caucasian-American and African-American men with
arthritis impairment in different income groups to be unable to
walk ¼ of a mile without special equipment, after adjusting for
age (r=+0.213, N=340, p<0.000). Among Caucasian-American
women with household incomes at or above $20,000, arthritis
impairment also was positively correlated with being unable to
walk ¼ of a mile without special equipment, after adjusting for
age. However, this partial correlation was very low (r=+0.047,
N=3,150, p<0.008).
Conclusions:These ﬁndings highlight the need to screen for and
aggressively manage arthritis-related pain and disability among
women, especially low-income African-American women.
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Purpose: Hypertension is a common comorbidity among pa-
tients with osteoarthritis (OA). Traditional NSAIDs used to treat
OA are known to increase blood pressure or to attenuate the
effect of antihypertensive medications. The goal of this analy-
sis was to model the 24 hr systolic ambulatory blood pressure
(SABP) proﬁle into long-term cardiovascular outcomes of a hy-
pothetical cohort of 100,000 controlled hypertensive OA patients
treated with lumiracoxib 100 mg versus ibuprofen 600 mg tid.
Methods: SABP proﬁle was based on results from a 4-week
clinical trial which showed signiﬁcant changes associated with
ibuprofen (+ 2.2 mmHg) vs lumiracoxib (-2.7 mmHg). Framing-
ham risk equations were used in an interactive Excel-based
model to extrapolate these results over a 10-year period and
predict the relationship between SABP changes and the de-
velopment of coronary heart disease (CHD), cerebrovascular
disease (CVD) and congestive heart failure (CHF). Inputs in the
model included common risk factors (age, gender, cardiovas-
cular disease, diabetes, left ventricular hypertrophy, total/HDL
ratio, smoking, and atrial ﬁbrillation), change in 24 hr SABP, and
acute and post-event costs for each of the outcomes of interest
obtained from published sources. Modeled outcomes included
the number of events and the associated costs of managing
these events in ibuprofen and lumiracoxib-treated hypertensive
OA patients.
Results: Table shows outcomes and costs in a cohort of 100,000
patients with the following characteristics: 64 yrs; female, base-
line SABP 127mmHg; total/HDL ratio 4.7; and negative history
of smoking, cardiovascular disease, left ventricular hypertrophy,
atrial ﬁbrillation, or diabetes.
Ibuprofen Lumiracoxib Events Avoided
# MI events 8,761 8,201 560
# Stroke events 5,997 5,244 753
New CHF diagnoses 1,682 1,659 23
Total CV-related deaths 4,759 4,332 427
Costs Avoided
MI Costs $141,374,086 $132,215,429 $9,158,656
Stroke Costs $242,578,501 $212,080,895 $30,497,606
CHF Costs $59,005,390 $58,152,872 $30,497,606
Total Costs 442,957,977 $402,449,196 $40,508,780
Conclusions: Modeling of differential treatment effect on clinical
trial blood pressure data showed that treatment of OA with
lumiracoxib vs a traditional NSAID in a hypertensive population
results in signiﬁcant cardiovascular events avoided and reduced
costs. Future work should address how clinic blood pressure
measures affect results relative to the ambulatory measures
used here.
